TuHURA Biosciences (HURA) Free Cash Flow (2010 - 2026)

TuHURA Biosciences' Free Cash Flow history runs 17 years deep, the most recent figure standing at -$4.5 million for Q1 2026.

• In Q1 2026, Free Cash Flow rose 4.39% year-over-year to -$4.5 million; the TTM figure through Mar 2026 stood at -$27.3 million (down 5.85% YoY), while the FY2025 annual figure was -$27.5 million, down 87.9% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$4.5 million, up from -$5.3 million in the prior quarter.
• The five-year high for Free Cash Flow was $3.5 million in Q2 2023, with the low at -$12.3 million in Q3 2024.
• The 5-year median for Free Cash Flow is -$5.3 million (2025), against an average of -$5.4 million.
• The sharpest annual moves came in 2023 and 2024: Free Cash Flow surged 80.05% in 2023, then sank 832.56% in 2024.
• TuHURA Biosciences' Free Cash Flow stood at -$7.2 million in 2022, then jumped by 52.11% to -$3.5 million in 2023, then slumped by 255.58% to -$12.3 million in 2024, then jumped by 56.49% to -$5.3 million in 2025, then rose by 16.5% to -$4.5 million in 2026.
• Business Quant data shows HURA's Free Cash Flow at -$4.5 million in Q1 2026, -$5.3 million in Q4 2025, and -$11.1 million in Q3 2025.